First Tracks Biotherapeutics When-Issued
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TRAXV and buy or sell other stocks, ETFs, and their options commission-free!About TRAXV
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101.
CEODaniel R. Faga
CEODaniel R. Faga
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded
Founded
Employees—
Employees—
TRAXV Key Statistics
Market cap882.62M
Market cap882.62M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.37K
Average volume2.37K
High today$25.40
High today$25.40
Low today$23.62
Low today$23.62
Open price$24.10
Open price$24.10
Volume6.60K
Volume6.60K
52 Week high$25.40
52 Week high$25.40
52 Week low$19.00
52 Week low$19.00
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.